Literature DB >> 10678767

Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures.

D J Kim1, S A Thayer.   

Abstract

The effects of cannabinoids on synaptic transmission were measured optically in rat hippocampal cultures. Synaptic release sites were labeled with the fluorescent dye FM1-43 in a stimulus-dependent manner. Action potential-induced release of FM1-43 required extracellular Ca2+ and was inhibited 65 +/- 3% by blockade of high-threshold voltage-gated Ca2+ channels with omega-grammotoxin SIA (300 nM). The cannabimimetic drug, Win 55212-2 (300 nM), inhibited FM1-43 release by 51 +/- 3%. The inhibition produced by Win55212-2 was blocked by the CB1 cannabinoid receptor antagonist, SR141716 (1 microM). The intensity of FM1-43 labeled puncta ranged 4-fold, although the inhibition produced by Win55212-2 was distributed normally across synaptic sites of various labeling intensities. The FM1-43-based optical method appears promising for the study of the effects of cannabinoids and other drugs on synaptic networks. These results indicate that cannabimimetics act presynaptically to inhibit the release of neurotransmitter and that this inhibition is observed uniformly at boutons of varied activity levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10678767     DOI: 10.1016/s0006-8993(99)02210-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus.

Authors:  J J Rodriguez; K Mackie; V M Pickel
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

2.  Further Evidence for the Neuroplastic Role of Cannabinoids: A Study in Organotypic Hippocampal Slice Cultures.

Authors:  Laura Romina Caltana; Bernd Heimrich; Alicia Brusco
Journal:  J Mol Neurosci       Date:  2015-02-03       Impact factor: 3.444

3.  Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release.

Authors:  Giampaolo Mereu; Mauro Fà; Luca Ferraro; Raffaele Cagiano; Tiziana Antonelli; Maria Tattoli; Veronica Ghiglieri; Sergio Tanganelli; Gian Luigi Gessa; Vincenzo Cuomo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-04       Impact factor: 11.205

Review 4.  Cannabinoids and neuroprotection.

Authors:  R I Grundy; M Rabuffetti; M Beltramo
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.590

Review 5.  Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.

Authors:  Jeannie Hwang; Crista Adamson; David Butler; David R Janero; Alexandros Makriyannis; Ben A Bahr
Journal:  Life Sci       Date:  2009-06-13       Impact factor: 5.037

6.  Neuroprotection of retinal ganglion cells in vivo using the activation of the endogenous cannabinoid signaling system in mammalian eyes.

Authors:  Greg Maguire; Christy Eubanks; George Ayoub
Journal:  Neuronal Signal       Date:  2022-02-16

Review 7.  A critical review of cannabis in medicine and dentistry: A look back and the path forward.

Authors:  Ammaar H Abidi; Sahar S Alghamdi; Karen Derefinko
Journal:  Clin Exp Dent Res       Date:  2022-04-01

Review 8.  Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease.

Authors:  Timothy J Tracey; Frederik J Steyn; Ernst J Wolvetang; Shyuan T Ngo
Journal:  Front Mol Neurosci       Date:  2018-01-23       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.